Literature DB >> 12505824

Dexamphetamine for obsessive-compulsive disorder.

James B Woolley, Isobel Heyman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12505824     DOI： 10.1176/appi.ajp.160.1.183

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Cigarette smoking in obsessive-compulsive disorder and unaffected parents of OCD patients.

Authors:  Amitai Abramovitch; Diego A Pizzagalli; Daniel A Geller; Lillian Reuman; Sabine Wilhelm
Journal:  Eur Psychiatry       Date:  2014-03-14       Impact factor: 5.361

Review 2.  Pharmacotherapeutic Strategies and New Targets in OCD.

Authors:  Christopher Pittenger
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 3.  Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder.

Authors:  Elizabeth Shephard; Emily R Stern; Odile A van den Heuvel; Daniel L C Costa; Marcelo C Batistuzzo; Priscilla B G Godoy; Antonio C Lopes; Andre R Brunoni; Marcelo Q Hoexter; Roseli G Shavitt; Y C Janardhan Reddy; Christine Lochner; Dan J Stein; H Blair Simpson; Euripedes C Miguel
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

4.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

Review 5.  Comorbidity Between Attention Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder Across the Lifespan: A Systematic and Critical Review.

Authors:  Amitai Abramovitch; Reuven Dar; Andrew Mittelman; Sabine Wilhelm
Journal:  Harv Rev Psychiatry       Date:  2015 Jul-Aug       Impact factor: 3.732

6.  Methylphenidate-induced obsessive-compulsive symptoms: A case report and review of literature.

Authors:  Soumya Jhanda; Neha Singla; Sandeep Grover
Journal:  J Pediatr Neurosci       Date:  2016 Oct-Dec

Review 7.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.